These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29515413)

  • 1. CSF-ctDNA SMSEQ Analysis to Tailor the Treatment of a Patient with Brain Metastases: A Case Report.
    Huang WT; Lu NM; Hsu WY; Chang SE; Atkins A; Mei R; Javey M
    Case Rep Oncol; 2018; 11(1):68-74. PubMed ID: 29515413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer.
    Escudero L; Martínez-Ricarte F; Seoane J
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33919036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis.
    Zhao Y; He JY; Zou YL; Guo XS; Cui JZ; Guo L; Bu H
    BMC Neurol; 2019 Dec; 19(1):331. PubMed ID: 31856745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the
    Zorofchian S; Lu G; Zhu JJ; Duose DY; Windham J; Esquenazi Y; Ballester LY
    Front Oncol; 2018; 8():382. PubMed ID: 30294590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases.
    Huang R; Xu X; Li D; Chen K; Zhan Q; Ge M; Zhou X; Liang X; Guan M
    Target Oncol; 2019 Jun; 14(3):343-350. PubMed ID: 31161597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease.
    Ballester LY; Glitza Oliva IC; Douse DY; Chen MM; Lan C; Haydu LE; Huse JT; Roy-Chowdhuri S; Luthra R; Wistuba II; Davies MA
    J Neuropathol Exp Neurol; 2018 Jul; 77(7):628-635. PubMed ID: 29873738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases.
    Siravegna G; Geuna E; Mussolin B; Crisafulli G; Bartolini A; Galizia D; Casorzo L; Sarotto I; Scaltriti M; Sapino A; Bardelli A; Montemurro F
    ESMO Open; 2017; 2(4):e000253. PubMed ID: 29067216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tapping into the genome: the role of CSF ctDNA liquid biopsy in glioma.
    Friedman JS; Hertz CAJ; Karajannis MA; Miller AM
    Neurooncol Adv; 2022 Nov; 4(Suppl 2):ii33-ii40. PubMed ID: 36380863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors.
    Yan W; Xu T; Zhu H; Yu J
    Onco Targets Ther; 2020; 13():719-731. PubMed ID: 32158224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Utility of Liquid Biopsy in Central Nervous System Malignancies.
    Nevel KS; Wilcox JA; Robell LJ; Umemura Y
    Curr Oncol Rep; 2018 Jun; 20(8):60. PubMed ID: 29876874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of cerebrospinal fluid liquid biopsies in central nervous system tumors.
    Diaz M; Chudsky S; Pentsova E; Miller AM
    Transl Oncol; 2024 Mar; 41():101881. PubMed ID: 38218027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors.
    McEwen AE; Leary SES; Lockwood CM
    Front Cell Dev Biol; 2020; 8():45. PubMed ID: 32133357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
    Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X
    Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers for brain tumor detection: clinical roles and current progress.
    Xiao F; Lv S; Zong Z; Wu L; Tang X; Kuang W; Zhang P; Li X; Fu J; Xiao M; Wu M; Wu L; Zhu X; Huang K; Guo H
    Am J Transl Res; 2020; 12(4):1379-1396. PubMed ID: 32355549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report.
    Namløs HM; Zaikova O; Bjerkehagen B; Vodák D; Hovig E; Myklebost O; Boye K; Meza-Zepeda LA
    BMC Cancer; 2017 Jan; 17(1):29. PubMed ID: 28061772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Characterization of Brain Metastases in the Era of Targeted Therapy.
    Han CH; Brastianos PK
    Front Oncol; 2017; 7():230. PubMed ID: 28993799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors.
    Ramkissoon LA; Pegram W; Haberberger J; Danziger N; Lesser G; Strowd R; Dahiya S; Cummings TJ; Bi WL; Abedalthagafi M; Sathyan P; McGregor K; Reddy P; Severson E; Williams E; Lin D; Edgerly C; Huang RSP; Hemmerich A; Creeden J; Brown C; Venstrom J; Hegde P; Ross JS; Alexander BM; Elvin J; Ramkissoon SH
    Front Neurol; 2020; 11():544680. PubMed ID: 33192972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid: A unique source of circulating tumor DNA with broad clinical applications.
    Hickman RA; Miller AM; Arcila ME
    Transl Oncol; 2023 Jul; 33():101688. PubMed ID: 37196447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The feasibility of using mutation detection in ctDNA to assess tumor dynamics.
    Yi X; Ma J; Guan Y; Chen R; Yang L; Xia X
    Int J Cancer; 2017 Jun; 140(12):2642-2647. PubMed ID: 28124376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
    Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
    Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.